GSK aims to get triple therapy approved for asthma in US

GlaxoSmithKline and development partner Innoviva have filed a dossier with the FDA, in a bid to get their triple therapy approved to keep asthma at bay.

How to make digital adoption a smooth journey

Four big pharma experts explain the challenges companies face in adopting digital tech and what trends are likely to drive digital commercial strategies in the next few years.

Harnessing data and insights for success

Ahead of the eyeforpharma Awards shortlist announcement this week, we spoke to judge and commercial insights executive Peter Barschdorff about how data and insights are changing pharma

GSK announces US leadership changes

GlaxoSmithKline has poached Merck KGaA's Maya Martinez-Davis to head up its US Pharmaceuticals division as it announces current president Jack Bailey will be stepping down at the end of the

GSK eyeing industry vet Jonathan Symonds as new chair; repor...